 |
MorphoSys AG
MOR
|
1.75 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Aeterna Zentaris
AEZS
|
7.87 |
- |
5.93 % |
$ 314 M |
Canada |
 |
Albireo Pharma
ALBO
|
13.3 |
- |
-0.23 % |
$ 916 M |
USA |
 |
I-Mab
IMAB
|
94.1 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
1.96 K |
- |
2.54 % |
$ 160 B |
France |
 |
Ascendis Pharma A/S
ASND
|
947 |
$ 220.94 |
2.51 % |
$ 5 B |
Danmark |
 |
Aptinyx
APTX
|
204 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Midatech Pharma plc
MTP
|
137 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
MediWound Ltd.
MDWD
|
6.04 |
$ 17.08 |
2.83 % |
$ 465 M |
Israel |
 |
Amphastar Pharmaceuticals
AMPH
|
1.73 |
$ 19.7 |
2.44 % |
$ 921 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
65.5 |
- |
- |
$ 26.5 M |
USA |
 |
Mesoblast Limited
MESO
|
127 |
$ 15.54 |
8.48 % |
$ 10.1 B |
Australia |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 |
- |
- |
$ 7.46 M |
Israel |
 |
AgeX Therapeutics
AGE
|
0.099 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Acorda Therapeutics
ACOR
|
0.142 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Acasti Pharma
ACST
|
0.203 |
- |
4.01 % |
$ 150 M |
Canada |
 |
BeiGene, Ltd.
BGNE
|
66.4 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Mirum Pharmaceuticals
MIRM
|
10.4 |
$ 90.9 |
3.44 % |
$ 4.56 B |
USA |
 |
bluebird bio
BLUE
|
2.27 |
- |
- |
$ 546 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 |
- |
- |
- |
Russia |
 |
Cara Therapeutics
CARA
|
2.58 |
- |
-3.03 % |
$ 260 M |
USA |
 |
Adverum Biotechnologies
ADVM
|
76.4 |
- |
- |
$ 86.2 M |
USA |
 |
Acer Therapeutics
ACER
|
25.8 |
- |
2.71 % |
$ 14 M |
USA |
 |
Advaxis
ADXS
|
144 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
MediciNova
MNOV
|
169 |
$ 1.44 |
-0.68 % |
$ 70.7 M |
USA |
 |
Autolus Therapeutics plc
AUTL
|
1.37 K |
$ 1.36 |
3.03 % |
$ 347 M |
Britain |
 |
CytomX Therapeutics
CTMX
|
12.2 |
$ 4.41 |
3.98 % |
$ 608 M |
USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
130 |
- |
-5.98 % |
$ 34.1 M |
USA |
 |
ChemoCentryx
CCXI
|
0.0564 |
- |
- |
$ 3.74 B |
USA |
 |
Merck & Co.
MRK
|
4.78 |
$ 118.9 |
2.17 % |
$ 297 B |
USA |
 |
Dynavax Technologies Corporation
DVAX
|
6.24 |
- |
- |
$ 2.02 B |
USA |
 |
BioDelivery Sciences International
BDSI
|
1.85 |
- |
-4.8 % |
$ 255 M |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
489 |
- |
- |
$ 1.01 B |
USA |
 |
CureVac N.V.
CVAC
|
281 |
- |
- |
$ 867 M |
Germany |
 |
Neurocrine Biosciences
NBIX
|
5.05 |
$ 131.82 |
3.1 % |
$ 13.1 B |
USA |
 |
Arbutus Biopharma Corporation
ABUS
|
60.1 |
$ 4.56 |
5.68 % |
$ 874 M |
Canada |
 |
Homology Medicines
FIXX
|
23.8 |
- |
0.77 % |
$ 53.4 M |
USA |
 |
AIkido Pharma
AIKI
|
1.08 |
- |
1.93 % |
$ 17.4 M |
USA |